Even in aggressive scenarios for reduced consumption related to GLP-1 use, modest gains to life expectancy can more than offset the impact over time. Indeed, because obesity-related diseases cut years off average lifespans, treatment with GLP-1 drugs can add years (up to 14 years) to the lives of those who take them
This deficiency can lead to difficulties in controlling hunger and maintaining healthy blood sugar levels, creating a cycle that makes weight loss challenging
Reviewers report polarized outcomes: some patients see modest results, many see no measurable response and request a switch to injectables
Endurance and resistance or weight training are effective in slowing down muscle loss accompanying weight loss
Drug designers are creating multi-agonists that stimulate more than one receptor, potentially amplifying results
Mood: Note any changes in anxiety or low mood